Transplantation for myocarditis: A controversy revisited

Edward D. Moloney, Jim J. Egan, Peter Kelly, Alfred E. Wood, Leslie T Jr. Cooper

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Myocarditis is a major cause of end-stage heart failure and is responsible for up to 10% of cases of idiopathic dilated cardiomyopathy (IDC). Worldwide, approximately 45% of all heart transplants are performed for IDC and up to 8% for myocarditis. Early reports suggested that survival after transplantation for myocarditis was poor and patients had an increased risk of rejection. More recently, larger case series suggest that overall survival after transplantation for myocarditis is similar to survival after transplantation for other causes. However, certain disorders, including cardiac sarcoidosis and giant cell myocarditis (GCM), require heightened surveillance for post-transplantation disease recurrence. We present the case of a 42-year-old man with recurrence of GCM 8 years after transplantation and review the literature on the role of cardiac transplantation for patients with myocarditis.

Original languageEnglish (US)
Pages (from-to)1103-1110
Number of pages8
JournalJournal of Heart and Lung Transplantation
Volume24
Issue number8
DOIs
StatePublished - Aug 2005

Fingerprint

Myocarditis
Transplantation
Dilated Cardiomyopathy
Giant Cells
Survival
Recurrence
Heart Transplantation
Sarcoidosis
Heart Failure
Transplants

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Transplantation

Cite this

Transplantation for myocarditis : A controversy revisited. / Moloney, Edward D.; Egan, Jim J.; Kelly, Peter; Wood, Alfred E.; Cooper, Leslie T Jr.

In: Journal of Heart and Lung Transplantation, Vol. 24, No. 8, 08.2005, p. 1103-1110.

Research output: Contribution to journalArticle

Moloney, Edward D. ; Egan, Jim J. ; Kelly, Peter ; Wood, Alfred E. ; Cooper, Leslie T Jr. / Transplantation for myocarditis : A controversy revisited. In: Journal of Heart and Lung Transplantation. 2005 ; Vol. 24, No. 8. pp. 1103-1110.
@article{3cb181f1528640c3ae7f4f940401e56d,
title = "Transplantation for myocarditis: A controversy revisited",
abstract = "Myocarditis is a major cause of end-stage heart failure and is responsible for up to 10{\%} of cases of idiopathic dilated cardiomyopathy (IDC). Worldwide, approximately 45{\%} of all heart transplants are performed for IDC and up to 8{\%} for myocarditis. Early reports suggested that survival after transplantation for myocarditis was poor and patients had an increased risk of rejection. More recently, larger case series suggest that overall survival after transplantation for myocarditis is similar to survival after transplantation for other causes. However, certain disorders, including cardiac sarcoidosis and giant cell myocarditis (GCM), require heightened surveillance for post-transplantation disease recurrence. We present the case of a 42-year-old man with recurrence of GCM 8 years after transplantation and review the literature on the role of cardiac transplantation for patients with myocarditis.",
author = "Moloney, {Edward D.} and Egan, {Jim J.} and Peter Kelly and Wood, {Alfred E.} and Cooper, {Leslie T Jr.}",
year = "2005",
month = "8",
doi = "10.1016/j.healun.2004.06.015",
language = "English (US)",
volume = "24",
pages = "1103--1110",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "8",

}

TY - JOUR

T1 - Transplantation for myocarditis

T2 - A controversy revisited

AU - Moloney, Edward D.

AU - Egan, Jim J.

AU - Kelly, Peter

AU - Wood, Alfred E.

AU - Cooper, Leslie T Jr.

PY - 2005/8

Y1 - 2005/8

N2 - Myocarditis is a major cause of end-stage heart failure and is responsible for up to 10% of cases of idiopathic dilated cardiomyopathy (IDC). Worldwide, approximately 45% of all heart transplants are performed for IDC and up to 8% for myocarditis. Early reports suggested that survival after transplantation for myocarditis was poor and patients had an increased risk of rejection. More recently, larger case series suggest that overall survival after transplantation for myocarditis is similar to survival after transplantation for other causes. However, certain disorders, including cardiac sarcoidosis and giant cell myocarditis (GCM), require heightened surveillance for post-transplantation disease recurrence. We present the case of a 42-year-old man with recurrence of GCM 8 years after transplantation and review the literature on the role of cardiac transplantation for patients with myocarditis.

AB - Myocarditis is a major cause of end-stage heart failure and is responsible for up to 10% of cases of idiopathic dilated cardiomyopathy (IDC). Worldwide, approximately 45% of all heart transplants are performed for IDC and up to 8% for myocarditis. Early reports suggested that survival after transplantation for myocarditis was poor and patients had an increased risk of rejection. More recently, larger case series suggest that overall survival after transplantation for myocarditis is similar to survival after transplantation for other causes. However, certain disorders, including cardiac sarcoidosis and giant cell myocarditis (GCM), require heightened surveillance for post-transplantation disease recurrence. We present the case of a 42-year-old man with recurrence of GCM 8 years after transplantation and review the literature on the role of cardiac transplantation for patients with myocarditis.

UR - http://www.scopus.com/inward/record.url?scp=23744438016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23744438016&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2004.06.015

DO - 10.1016/j.healun.2004.06.015

M3 - Article

C2 - 16102447

AN - SCOPUS:23744438016

VL - 24

SP - 1103

EP - 1110

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 8

ER -